<DOC>
	<DOCNO>NCT02447068</DOCNO>
	<brief_summary>This proof concept , investigator blind study evaluate efficacy safety novel combination home narrow band ultraviolet B ( NBUVB ) lamp occlusive dressing adult subject mild moderate psoriasis vulgaris . Four interpatient arm use compare efficacy combination NBUVB occlusive dressing light alone dress alone treatment . Ten patient enrol 6 week study .</brief_summary>
	<brief_title>Luma Light System Proof Concept Study Subjects With Mild Moderate Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Male female race , 18 65 ( inclusive ) year age . Verbal write informed consent obtain subject . Has clinical diagnosis mild moderate psoriasis Screening Baseline visit . Has IGA score 2 3 . Target plaque assessment ( TPA ) score 69 score least 2 3 different psoriasis sign symptom ( erythema , plaque elevation , scale ) Has least 4 plaque least 10 cm2 TPA score differ score 1 Is good general health determine Investigator base subject 's medical history , vital sign physical examination . Females childbearing potential must negative urine pregnancy test result . Females childbearing potential agree use acceptable method contraception screen visit continuously 30 day end treatment . Subject agree use Sponsor provide cleanser lotion study period . Subject willing able return study visit . Presence psoriasis previously treat prescription medication prior Screening visit nonresponsive treatment , determine Investigator . Presence concurrent skin condition could interfere evaluation study device , determine Investigator . Female pregnant , nursing infant , plan pregnancy study period . Treatment investigational drug device within 30 day 5 halflives ( whichever longer ) prior Baseline visit , concurrent participation another clinical trial investigational drug device . History melanoma . Subject medical , social psychological condition , opinion Investigator , preclude receive pretreatment , require treatment , posttreatment procedure evaluation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>